2.94 RUB
168.86 M RUB
1.37 B RUB
4.67 M
About ARTGEN
Sector
Industry
Headquarters
Moscow
Website
Founded
2003
ISIN
RU000A0JNAB6
Artgen Biotech PJSC engages in the discovery, research, development, and marketing of proprietary products and services in the field of regenerative medicine, medical genetics, bio-insurance, gene therapy, and biopharmaceutics. Its research and development involves gemacell and cryocell; service for personal regeneration of bone and of gum; nucleostim; preventive treatment program for primary immunodeficiency diseases; human artificial chromosome; development of drugs using histone proteins; and development of drugs using a novel technology employing polysialic acid. The company was founded by Isaev Alexandrovich Artur on November 3, 2003 and is headquartered in Moscow, Russia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ABIO is 88.30 RUB — it has increased by 0.52% in the past 24 hours. Watch ARTGEN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on RUS exchange ARTGEN stocks are traded under the ticker ABIO.
ABIO stock has fallen by −2.97% compared to the previous week, the month change is a −11.70% fall, over the last year ARTGEN has showed a −9.90% decrease.
ABIO reached its all-time high on Nov 11, 2021 with the price of 177.00 RUB, and its all-time low was 7.60 RUB and was reached on Sep 26, 2011. View more price dynamics on ABIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ABIO stock is 2.57% volatile and has beta coefficient of −0.13. Track ARTGEN stock price on the chart and check out the list of the most volatile stocks — is ARTGEN there?
Yes, you can track ARTGEN financials in yearly and quarterly reports right on TradingView.
ABIO net income for the last half-year is 83.09 M RUB, while the previous report showed 136.98 M RUB of net income which accounts for −39.34% change. Track more ARTGEN financial stats to get the full picture.
No, ABIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARTGEN EBITDA is 400.86 M RUB, and current EBITDA margin is 24.14%. See more stats in ARTGEN financial statements.
Like other stocks, ABIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARTGEN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARTGEN technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARTGEN stock shows the sell signal. See more of ARTGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.